The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis (Q35764862)
Jump to navigation
Jump to search
scientific article published on 20 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis |
scientific article published on 20 May 2015 |
Statements
1 reference
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis (English)
1 reference
Maarten Van Roy
1 reference
Cedric Ververken
1 reference
Els Beirnaert
1 reference
Sven Hoefman
1 reference
Joost Kolkman
1 reference
Michel Vierboom
1 reference
Elia Breedveld
1 reference
Bert 't Hart
1 reference
Sofie Poelmans
1 reference
Lieselot Bontinck
1 reference
Alex Hemeryck
1 reference
Sandy Jacobs
1 reference
Judith Baumeister
1 reference
Hans Ulrichts
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference